News
Stopwatch starts on reviews of GSK's long-acting asthma drug
Regulators have started reviews of GSK's depemokimab, aiming to become the first drug for asthma that can be dosed twice a year.
News
Enhertu gets first okay for HER2-ultralow breast cancer
Enhertu gets much-anticipated new FDA approval in breast cancer that expands its label and makes it an earlier option in the treatment pathway.
News
Sage rejects Biogen takeover and launches review
Sage Therapeutics has unanimously rejected Biogen's acquisition offer of around $469 million, saying it "significantly undervalues" the company.
News
Italian decision sets up launch of Oncopeptides' Pepaxti
Oncopeptides hopes to reignite growth in multiple myeloma drug Pepaxti after getting reimbursement approval in Italy.
News
Pfizer offers $60m to settle prescriber kickback claims
Pfizer has paid $60m to settle US government allegations that its Biohaven unit made improper payments to prescribers of its migraine drug Nurtec ODT.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
